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ABSTRACT
General anesthetics are thought to act on both excitatory and
inhibitory neuronal pathways at both post- and presynaptic
sites. However, the literature in these regards is somewhat
controversial. The aim of the present study was to reassess the
relative importance of the various anesthetic actions using a
common preparation. Rat cortical neurons in primary culture
were used to record spontaneous miniature postsynaptic cur-
rents by the whole-cell patch-clamp technique. Halothane at
clinically relevant concentrations prolonged the decay phase of
spontaneous miniature inhibitory postsynaptic currents (mIP-
SCs) recorded in the presence of tetrodotoxin and at higher
concentrations decreased the frequency of mIPSCs. The
mIPSC amplitudes underwent little change. Spontaneous ac-
tion potential-dependent IPSCs recorded in the absence of
tetrodotoxin were similarly affected by halothane. Halothane
also decreased the frequency of spontaneous miniature non-
N-methyl-D-aspartate (NMDA) excitatory postsynaptic currents
(mEPSCs) as well as spontaneous action potential-dependent
NMDA EPSCs and non-NMDA EPSCs without affecting their
decay phase. The halothane effect on mIPSC and mEPSC
frequency was dependent on the external calcium concentra-
tion. In contrast to halothane, the only effect of propofol was the
prolongation of the decay phase of mIPSCs and IPSCs. The
prolongation of mIPSCs and IPSCs by halothane and propofol
coupled with the ineffectiveness on mEPSCs and EPSCs sug-
gests a selective postsynaptic modulation of GABAA receptors.
The additional calcium-dependent inhibition of mIPSC and
mEPSC frequency by halothane (but not propofol) suggests a
more general mechanism by this anesthetic on presynaptic
transmitter release.
It is reasonable to hold that anesthesia can be achieved by
enhancing neuronal inhibition, by decreasing neuronal exci-
tation, or by a combination of both. There is ample evidence
indicating that most general anesthetics potentiate GABAer-
gic inhibitory synaptic responses (Franks and Lieb, 1994;
Mody et al., 1994) and potentiate GABA-activated Cl cur-
rents (Nakahiro et al., 1989; Jones and Harrison, 1993; Inoue
et al., 1999). Studies with site-directed mutagenesis of the
GABAA receptor subunits point to the importance of the
second transmembrane domain in the potentiating action of
anesthetics (Mihic et al., 1997; Krasowski et al., 1998;
Koltchine et al., 1999). Thus, there is general agreement that
postsynaptic GABAA receptors are an important target for
general anesthetics.
The excitatory synaptic system is also a potential target of
general anesthetics (Peoples and Weight, 1997). Excitatory
postsynaptic potentials (EPSPs) and orthodromic population
spikes in hippocampus were depressed by isoflurane and
halothane (MacIver et al., 1996; Wakasugi et al., 1999). Ex-
citatory postsynaptic currents (EPSCs) induced by NMDA
and AMPA were suppressed by isoflurane and halothane
(Wakamori et al., 1991; de Sousa et al., 2000).
Currents evoked in NMDA, AMPA, and kainate receptors
expressed in Xenopus oocytes were all inhibited by enflurane
with approximately the same potency (Lin et al., 1993). Al-
though isoflurane, enflurane, and halothane inhibited kai-
nate responses in Xenopus oocytes expressing GluR1, GluR3,
or GluR2  3 receptors, they potentiated kainate-induced
currents in GluR6 receptors (Dildy-Mayfield et al., 1996).
Glycine 819 in transmembrane region 4 was shown to be
important for halothane-induced potentiation of kainate-in-
duced currents (Minami et al., 1998).
In addition to postsynaptic receptor modulation, general
anesthetics have been shown to act on presynaptic sites.
Whereas halothane inhibited NMDA and non-NMDA recep-
tor-mediated EPSCs, currents induced by direct application
of NMDA or AMPA were less sensitive to halothane, suggest-
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ing that the glutamate release from presynaptic terminals is
inhibited by this anesthetic (Kirson et al., 1998). Presynaptic
modulation was also suggested by the observation of paired
pulse facilitation of EPSPs caused by halothane and isoflu-
rane (MacIver et al., 1996).
Thus, despite the well established role of inhibitory neuro-
transmission in general anesthesia, the data on both excita-
tory synaptic transmission and presynaptic transmitter re-
lease remain controversial. One of the reasons for the
variable data may be due to the diverse preparations and
techniques used by different investigators to examine vari-
ous processes involving synaptic transmission. It is impor-
tant to conduct systematic experiments on the various pa-
rameters likely to be involved in general anesthesia using the
same preparation.
In our previous studies using rat hippocampal and cortical
neurons in primary culture, we were able to record sponta-
neous excitatory and inhibitory postsynaptic currents (EP-
SCs and IPSCs, respectively), which could be isolated by
applying specific receptor blockers or by manipulation of
external and internal ionic compositions (Marszalec et al.,
1996, 1998). These spontaneous EPSCs and IPSCs depend in
part on the propagation of action potentials throughout the
neuronal synaptic networks redeveloped in culture. When
action potentials are blocked by tetrodotoxin (TTX), sponta-
neous miniature IPSCs (mIPSCs) and miniature EPSCs
(mEPSCs) could still be observed (Marszalec et al., 1996).
Because mIPSCs and mEPSCs represent responses due to
the quantal release of neurotransmitters, they are excellent
parameters to analyze the drug action on transmitter/recep-
tor kinetics because the spatial and temporal distortions of
evoked or exogenous transmitter-induced responses are min-
imized (Mody et al., 1994). Drug-induced changes in the
amplitude and time course of mEPSCs and mIPSCs indicate
actions on postsynaptic receptors, whereas drug-induced
changes in the frequency of mEPSCs and mIPSCs are largely
indicative of actions on presynaptic release. In the present
study, we analyzed the effects of halothane and propofol on
spontaneous mEPSCs and mIPSCs in the presence of TTX as
well as on spontaneous EPSCs and IPSCs recorded in the
absence of the sodium channel blocker.
Materials and Methods
Cell Preparation. Rat cortical neurons in primary culture were
used as a source of functional synapses. In this preparation, neurons
reform a synaptic network expressing GABAergic, NMDA glutama-
tergic, and non-NMDA (AMPA/kainate) glutamatergic postsynaptic
receptors (Marszalec et al., 1996). Their synaptic activities could be
observed in the absence of TTX by recording spontaneous compound
EPSCs and IPSCs, which depend in part on the propagation of action
potentials throughout the neuronal network. However, in the pres-
ence of TTX to block action potential activity spontaneous GABAer-
gic and glutamatergic postsynaptic currents continued to be ob-
served as smaller unitary mEPSCs and mIPSCs. EPSCs, IPSCS,
mEPSCs, and mIPSCs could all be isolated pharmacologically by
adding appropriate blockers. NMDA-EPSCs and non-NMDA-EPSCs
could also be isolated by adding selective blocking agents.
Cortical neurons were cultured by the method previously used for
hippocampal cells (Marszalec and Narahashi, 1993). In brief, 17-day
embryonic rat pups were removed from a pregnant Sprague-Dawley
rat under methoxyflurane anesthesia. Small wedges of frontal cortex
were excised and incubated in a phosphate-buffered saline solution
containing 0.25% (w/v) trypsin (type XI; Sigma-Aldrich, St. Louis,
MO) for 25 min at 37°C. After mechanical trituration by repeated
passages through a Pasteur pipette, the dissociated cells were sus-
pended in Dulbecco’s modified Eagle’s medium with 10% (v/v) Ham’s
F-12 supplement, 2 mM glutamine, and 20 U penicillin/20 ng of
streptomycin per milliliter. The cells were placed into 25-mm culture
wells at a concentration of 200,000 cells/3 ml. Each well contained
five 12-mm glass coverslips with a confluent layer of glia that were
plated 2 to 4 weeks previously. This cortical/glia coculture was main-
tained in a humidified atmosphere of 90% air and 10% CO2 at 37°C.
The spontaneous activity of these cells increased over time and was
probably related to synaptic redevelopment (Muramoto et al., 1983).
Cells used in these experiments were cultured for 2 to 4 weeks. All
current recordings were made from pyramidal-shaped neurons, 30 to
50 m in diameter. Smaller oval bipolar cells were also present but
were not used for experimentation.
Electrophysiological Methods. Spontaneous postsynaptic cur-
rents were recorded by the standard whole-cell patch-clamp tech-
nique using an Axopatch 1B amplifier (Axon Instruments, Union
City, CA) at room temperature (22–25°C). Recording electrodes were
pulled from borosilicate glass (Kimble, Vineland, NJ) on a vertical
puller to a final resistance of 1.5 to 2.5 M when filled with internal
solution.
The external solution used for recording spontaneous synaptic
Fig. 1. Records of spontaneous mIPSCs and miniature non-NMDA exci-
tatory postsynaptic currents (mNN-EPSCs). mIPSCs before (control) (A)
and during (B) application of 0.6 mM halothane in the presence of 1 M
CNQX, 30 M APV, and 0.1 M TTX. The frequency of mIPSCs was
decreased and the current decay phase was prolonged by halothane.
mNN-EPSCs before (control) (C) and during (D) application of 0.6 mM
halothane in the presence of 20 M bicuculline, 30 M APV, and 0.1 M
TTX. Halothane had no effect on the amplitude and decay phase of
mNN-EPSCs. Holding potential was 70 mV.
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currents consisted of 150 mM NaCl, 5 mM KCl, 2.5 mM CaCl2, 5.5
mM HEPES-acid, 4.5 mM HEPES-Na, and 10 mM glucose, and pH
was adjusted to 7.3 with NaOH. To observe the NMDA-mediated
component of EPSCs, Mg2 was omitted from the external solution
to avoid voltage-dependent Mg2 block. The internal pipette solution
contained 140 mM KCl, 2.0 mM MgCl2, 1.0 mM CaCl2, 11 mM EGTA,
10 mM HEPES-acid, 2 mM Mg2ATP, and 0.2 mM Na-GTP, and
pH was adjusted to 7.3 with KOH.
To check the stability of recordings, access resistance was moni-
tored as a current response to a small hyperpolarizing voltage com-
mand. Changes should be no more than 20%.
Drug Application. The neuron-containing glass coverslip was
placed in a microscope-mounted recording chamber (0.5-ml volume)
into which control and drug-containing solutions were perfused at a
rate of 1 to 2 ml/min. Saturated halothane (Ayerst Laboratories, New
York, NY) solutions were made by stirring halothane in external
solution over 8 h in a sealed, glass container with very little air
space. Halothane test solutions were prepared by diluting the satu-
rated halothane solution with external solution immediately before
the experiment using sealed glass containers and glass pipettes.
Using 19F-NMR spectroscopy (GE-NMR Instruments, Fremont,
CA), the saturated solution was found to contain 18.0 mM halothane,
a value identical to that determined previously (Seto et al., 1992).
The solution diluted 80 times from the saturated solution was found
to contain 0.23 mM halothane.
The mIPSCs were isolated by bath application of 1 M 6-cyano-
7-nitroquinoxaline (CNQX) (Tocris Cookson, St. Louis, MO) and 30
M 2-amino-5-phosphonvaleric acid (APV) (Sigma/RBI, Natick, MA)
to block AMPA- and NMDA-mediated currents, respectively. In a
similar manner, mEPSCs were isolated in the presence of 20 M
bicuculline (Sigma-Aldrich) to block GABAergic currents. Action po-
tential-dependent synaptic events were abolished by adding 0.1 M
TTX to the external solution.
Use of Miniature IPSCs and EPSCs to Distinguish Pre- and
Postsynaptic Effects. The frequency of mIPSCs/mEPSCs was
taken as a measure of the presynaptic effects of experimental ma-
nipulation, whereas the amplitudes of these events were thought to
reflect postsynaptic processes (Banks and Pearce, 1999). According
to the quantum theory of vesicular release, miniature postsynaptic
currents are assumed to represent the spontaneous release of indi-
vidual vesicles or quanta of neurotransmitter from the presynaptic
membrane. Thus, drug-induced changes in the frequency of mIPSCs
Fig. 2. Effects of various concentrations of halothane on the amplitude, frequency, and decay time course of spontaneous mIPSCs and miniature
non-NMDA EPSCs (mNN-EPSCs). Data are normalized to control values and plotted against the anesthetic concentration. A, halothane had little or
no effect on mIPSC and mNN-EPSC amplitude except at a concentration of 1.2 mM, which decreased the mIPSC amplitude (P  0.05). B, halothane
decreased the frequency of mIPSCs and mNN-EPSCs at 0.6 and 1.2 mM (P  0.05). C, halothane increased the decay time constant of mIPSCs but
not that of mNN-NMDA EPSCs. D, halothane increased the total charge transfer per mIPSC. The number of experiments is indicated in parentheses.
164 Kitamura et al.
or mEPSCs are indicative of presynaptic actions. However, if a drug
blocks postsynaptic receptors sufficiently, the frequency of events
would tend to decrease as well.
Data Acquisition and Analysis. Miniature postsynaptic cur-
rents were continuously recorded at a holding potential of 70 mV
for 3 min. Signals were filtered at 2 kHz and digitized at 200-s
sample interval. The algorithm for synaptic event detection started
with an estimation of baseline signal variance using a user-specified
segment of digitized data free of events. Synaptic currents were
analyzed using a software package (Mini Analysis Program; Synap-
tosoft, Inc., Decatur, GA). The amplitude threshold was set as 3
noise, where noise was measured during periods when no visually
detectable events occurred. Under control conditions noise was typ-
ically 4 pA, and the detection algorithm successfully detected more
than 98% of miniature currents. When anesthetic application caused
an increase in noise, the final 3-min records obtained during the
application of the highest concentration of anesthetic were analyzed
to determine the event threshold and were used to analyze all the
data obtained at lower concentrations from that particular cell. From
this baseline, the peak current was determined and the event was
followed until the current declined to 5% of the baseline mean. A
single exponential function was used to fit selected events using a
nonlinear curve fitting routine to estimate the time constant. The
current amplitude (in picoamperes), the time constant of current
decay (in milliseconds), and the total charge integrated between the
peak and the 5% baseline value were tabulated for statistical com-
parisons between control and halothane- or propofol-treated cells.
Statistical Analysis. All analysis, including curve fitting was
performed using pClamp software and Mini Analysis Program (see
above). Amplitudes and inter-event intervals of spontaneous synap-
tic currents in control versus test conditions were compared with the
use of the Kolmogorov-Smirnov test with the criterion of P  0.05.
The results were analyzed for significant differences by two-tailed
paired Students’s t tests. Due to the large variability observed from
cell to cell, the values of amplitude, frequency, and decay time of the
currents are expressed as the values relative to the control values.
Unless otherwise stated, data are presented as the mean  S.D.
Results
As reported previously (Marszalec et al., 1998), spontane-
ous IPSCs were observed when 1 M CNQX and 30 M APV
Fig. 3. Effects of halothane on the amplitude and frequency of spontaneous IPSCs, non-NMDA EPSCs (NN-EPSCs), and NMDA EPSCs (N-EPSCs).
Data are normalized to control values and plotted against the anesthetic concentration. Halothane had little of no effect on the amplitude (A) but
decreased the frequency of IPSCs, NN-EPSCs, and N-EPSCs (B). C, halothane increased the decay time constant of IPSCS but not that of NN-EPSCs
and N-EPSCs. D, halothane increased the total charge transfer per IPSC. The numbers of experiments are indicated in parentheses.
Halothane and Propofol on Synaptic Transmission 165
were present in the external bathing solution to block non-
NMDA and NMDA EPSCs, respectively. When TTX was
added to the bath at a concentration of 0.1 M, spontaneous
mIPSCs with much smaller amplitudes were discernible
(Fig. 1A, control). To observe spontaneous EPSCs, 20 M
bicuculline was added to the external solution to block
GABAA receptors (Marszalec et al., 1998). The additional
inclusion of 0.1 M TTX allowed us to observe spontaneous
mEPSCs. NMDA EPSCs and non-NMDA EPSCs could be
separately recorded by using 1 M CNQX and 30 M APV,
respectively. Miniature non-NMDA EPSCs were recorded by
inclusion of 0.1 M TTX as well (Fig. 1C, control). Miniature
NMDA EPSCs of smaller amplitudes were recorded in the
presence of 1 M CNQX and 0.1 M TTX (data not shown).
Effects of Halothane on Miniature IPSCs and Minia-
ture non-NMDA EPSCs. Halothane at concentrations
ranging from 0.15 to 1.2 mM had little or no effect on the
amplitude of mIPSCs and non-MNDA mEPSCs observed in
the presence of TTX. Only 1.2 mM halothane slightly but
significantly decreased in the amplitude of mIPSCs detected
(Fig. 2A). In contrast, the frequency of mIPSCs and non-
MNDA mEPSCs was significantly decreased by halothane at
0.6 and 1.2 mM (Fig. 2B), reflecting inhibition of the presyn-
aptic release mechanism. Marked differential actions of halo-
thane were observed in the time constant of current decay.
Although the decay time constant of mIPSCs was signifi-
cantly increased by 0.3, 0.6, and 1.2 mM halothane (Fig. 2C),
indicative of postsynaptic effects, that of non-NMDA mEP-
SCs was not affected at all (Fig. 2C). Reflecting the increase
in decay time constant of mIPSCs, the total charge transfer
per mIPSC was greatly increased by 0.3, 0.6, and 1.2 mM
halothane (Fig. 2D). These results indicated that halothane
at 0.6 and 1.2 mM inhibited spontaneous release of both
inhibitory and excitatory transmitters while selectively pro-
longing mIPSCs even at a lower concentration of 0.3 mM.
Effects of Halothane on IPSCs and EPSCs. Spontane-
ous IPSCs and EPSCs were observed in the absence of TTX,
and their activities reflected not only transmitter release and
postsynaptic responses but also the conduction of impulses in
the neuronal network formed in culture. The effects of halo-
thane on IPSCs, non-NMDA EPSCs, and NMDA EPSCs were
similar to those on mIPSCs and non-NMDA mEPSCs de-
scribed in the preceding section. The amplitude of IPSCs and
NMDA EPSCs was slightly but significantly suppressed at a
high concentration (1.2 mM) of halothane, whereas that of
non-NMDA EPSCs was not affected (Fig. 3A). The frequency
of IPSCs, non-NMDA EPSCs, and NMDA EPSCs was mark-
edly decreased by 0.6 and 1.2 mM halothane (Fig. 3B). Al-
though the decay time constant and the total charge transfer
per IPSC were increased by halothane at 0.3, 0.6, and 1.2
mM, those of non-NMDA and NMDA EPSCs were not af-
fected (Fig. 3, C and D). The similarity of halothane action on
mIPSCs/mEPSCs and on IPSCs/EPSCs led us to the conclu-
sion that the involvement of impulse propagation in the
Fig. 4. A, effects of halothane (0.6 and 1.2 mM) on the frequency of
spontaneous miniature non-NMDA EPSCs (mNN-EPSCs) in the pres-
ence and absence of calcium in the external solution. The ordinate ex-
presses the amplitudes and frequencies normalized to the control condi-
tion of 2.5 mM calcium and 0 mM halothane. The percentage of decrease
in EPSC frequency observed with 0.6 mM halothane and 2.5 mM Ca2
was nearly identical to that of Ca2-free solution and no halothane, or
Ca2-free solution and 0.6 mM halothane. The EPSC amplitude was not
affected under any of these conditions.
Fig. 5. Records of mIPSCs before (A,
control) and during application of 3
M propofol. Propofol slowed the de-
cay phase of mIPSCs.
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neuronal network in halothane modulation of the presynap-
tic and postsynaptic mechanisms was less likely.
Effects of Halothane on Presynaptic Elements. To
elucidate the mechanism by which halothane might modu-
late transmitter release, experiments were performed to com-
pare the previously observed effects of halothane with those
recorded in calcium-free solution. Figure 4 illustrates the
comparison of the effect of various combinations of halothane
and calcium-free solution on non-NMDA mEPSCs. In agree-
ment with the results presented in Fig. 2A, halothane at 0.6
and 1.2 mM in the presence of the normal Ca2 concentration
of 2.5 mM significantly decreased the frequency of non-
NMDA mEPSCs while having no effect on their amplitudes.
Removal of calcium from the media had virtually the same
effect as that of halothane, decreasing the frequency while
causing no effect on the amplitude of non-NMDA mEPSCs.
Addition of 0.6 mM halothane to Ca2-free solution exerted
no further effect beyond that observed with Ca2-free solu-
tion alone. These results suggest that halothane may inhibit
calcium channels in the presynaptic terminals.
Effects of Propofol on Miniature IPSCs and Minia-
ture non-NMDA EPSCs. Records of mIPSCs before and
during application of 3 M propofol are shown in Fig. 5. No
marked changes in the mean amplitude and frequency of
mIPSCs were noted. Propofol at concentrations ranging from
0.1 to 10 M had no significant effect on the amplitude or
frequency of mIPSCs and non-NMDA mEPSCs (Fig. 6, A and
B). However, at 1 to 10 M propofol did cause an increase in
the current decay time constant and the total charge transfer
per mIPSC without effect on the decay of non-NMDA mEP-
Fig. 6. Effects of various concentrations of propofol on the amplitude, frequency, and decay time course of spontaneous mIPSCs and miniature
non-NMDA EPSCs (mNN-EPSCs). Data are normalized to control values and plotted against the anesthetic concentration. Propofol had no effect on
the amplitude (A) and frequency (B) of mIPSCs and mNN-EPSCs. However, propofol increased the decay time constant of mIPSCs but not that of
mNN-EPSCs (C), and increased the total charge transfer per mIPSC (D). The numbers of experiments are indicated in parentheses.
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SCs (Fig. 6, C and D). The lack of the propofol action on the
spontaneous transmitter release contrasts with the halo-
thane action.
Effects of Propofol on IPSCs and EPSCs. Although the
amplitude of IPSCs recorded in TTX-free solutions was not
altered by propofol at 10 M, that of non-NMDA and NMDA
EPSCs was decreased somewhat at 3 to 10 M and at 10 M,
respectively (Fig. 7A). The frequency of IPSCs, non-NMDA
EPSCs, and NMDA EPSCs was decreased by propofol only at
10 M (Fig. 7B).
Similar to the action of halothane, propofol at 1 to 10 M
slowed IPSC decay, resulting in an increase in the total
charge transfer per IPSC (Fig. 7, C and D). The decay time
constant of non-NMDA and NMDA EPSCs was not altered by
propofol (Fig. 7C).
Discussion
Surgical anesthesia is associated with several behavioral
phenomena, including hypnosis, amnesia, analgesia, and the
loss of reflexive movement. These phenomena undoubtedly
represent a complex integration of activity by neuronal net-
works within the brain and spinal cord. Our objective was to
study the interaction of the anesthetics halothane and propo-
fol with this neuronal system using a two-dimensional net-
work of cortical neurons in culture. The underlying hypoth-
esis of our study is that these anesthetics can alter the
presynaptic release and/or the postsynaptic responses of the
brain’s primary inhibitory and excitatory neurotransmitters,
namely, GABA and glutamate.
The reestablishment of synaptic networks in these cul-
tured cells is indicated by the spontaneous occurrence of
postsynaptic currents generated by the release of vesicular
GABA and glutamate, thus producing IPSCs and EPSCs,
respectively (Marszalec et al., 1996, 1998). The spontaneous
mIPSCs and mEPSCs observed in the presence of TTX arise
from the fusion of single neurotransmitter vesicles to the
presynaptic membrane and the release of their contents into
the synaptic cleft. Although the perfusion of 0.3 mM halo-
thane had no effect on the frequency of both mIPSCs and
mEPSCs, halothane at 0.6 mM decreased the frequency of
both mIPSCs and mEPSCs by approximately 20 and 30%,
respectively. The halothane concentration of 0.6 mM is equiv-
alent to approximately 2 MAC units, implying that this halo-
thane effect may be attained only at higher concentrations of
the anesthetic.
These are some discrepancies between the present results
and those reported recently with respect to the effects of
halothane on the frequency and amplitude of mIPSCs. The
mIPSC frequency was not affected by 0.3 mM halothane and
slightly (20%) decreased by 0.6 mM halothane in our ex-
periments using rat cortical neurons in culture. However,
variable increases in the mIPSC frequency by 0.35 mM halo-
thane in hippocampal pyramidal neurons and interneurons
were reported by Nishikawa and MacIver (2000, 2001) and
by Banks and Pearce (1999). The amplitudes of mIPSCs and
mEPSCs were not affected by 0.3 and 0.6 mM halothane in
the present study. In the studies of Nishikawa and MacIver
(2000, 2001) using hippocampal neurons, the mIPSC ampli-
tude was inhibited by approximately 20%, and the effect
progressed slowly requiring 15 to 20 min to reach a steady
state. However, Banks and Pearce (1999) did not see signif-
icant decreases in mIPSC amplitude in the presence of 0.6
mM halothane.
The reasons for the discrepancies are not completely clear,
yet at least four possible factors are conceivable. One is the
difference in material; we used cortical neurons and they
used hippocampal neurons. Second is the difference in the
methods used, i.e., long-term cultured neurons versus brain
slices. Third is the time period of exposure to halothane; in
our experiments, measurements were made 5 min after ex-
posure to halothane, whereas in the studies of Nishikawa
and MacIver (2000, 2001), the increase in mIPSC frequency
and the decrease in mIPSC amplitude progressed slowly
during halothane application, and the increase in frequency
seemed to be small after 5 min of exposure and became
prominent only after 10 to 20 min of exposure.
Fourth is the effect via neuronal nicotinic acetylcholine
(nACh) receptors. Rat cortex is reported to contain intrinsic
cholinergic neurons (Cauli et al., 1997). Presynaptic or pre-
terminal nACh receptors are known to modulate the release
of various transmitters, including GABA, glutamate, dopa-
mine, norepinephrine, and ACh itself (Role and Berg, 1996;
Colquhoun and Patrick, 1997; Léna and Changeux, 1997;
Lindstrom, 1997; Wonnacott, 1997; Alkondon et al., 2000),
and halothane blocks 42-type nACh receptors with an IC50
value of 105 M (Mori et al., 2001). Thus, the observed
decrease in the frequency of mIPSCs and mEPSCs by halo-
thane could be the result of inhibition of nACh receptors.
Halothane also reduced the frequency of spontaneous
events in the absence of TTX. Although halothane had no
significant effect on the frequency of IPSCs, non-NMDA EP-
SCs, and NMDA EPSCs at a concentration of 0.3 mM, it
decreased their frequencies at 0.6 mM. The amplitude of
these IPSCs and EPSCs was not affected at either 0.3 or 0.6
mM. These data on both frequency and amplitude agree with
those of mIPSCs and miniature non-NMDA EPSCs, suggest-
ing that propagation of action potentials in the synaptic
network is not involved in the action of halothane. Such
spontaneous bursts of currents resulting from action poten-
tial-dependent phasic transmitter release are observed ei-
ther in culture as whole-cell currents (Marszalec et al., 1996,
1998) or in vivo as rhythmic EEG waves recorded in the
resting brain (Weliky and Katz, 1999). In culture prepara-
tions, these synchronized bursts of activity spread through
the culture network in a wave-like manner. Studies have
found that the initiation of these action potentials is corre-
lated with spontaneous mEPSCs that summate to depolarize
a few random cells toward firing threshold and pacemaker
status (Köller et al., 1993; Siebler et al., 1993). It is reason-
able to expect that because halothane reduces the frequency
of spontaneous mEPSCs, it also could reduce the initiation
(and frequency) of the action potential-driven compound
postsynaptic responses in culture.
Because halothane affected the frequency of both gluta-
mate- and GABA-mediated quantal release in a similar man-
ner, it might be hypothesized that the underlying mechanism
involves one or more of the general processes leading to
vesicular fusion to the presynaptic membrane. One element
that participates in this process is the divalent cation cal-
cium. The experiments summarized in Fig. 4 show that the
frequency of spontaneous mEPSCs and mIPSCs is dependent
in part on the extracellular level of calcium. Note that the
frequency reductions observed with either 0.6 mM halothane
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or 0 mM external calcium are nearly identical. Furthermore,
the effect resulting from the combination of both modifica-
tions is not additive. Taken together, this suggests that the
halothane-induced decrease in mEPSC and mIPSC fre-
quency may be the result of a reduction in presynaptic cal-
cium channel activity or by an interference with the calcium-
dependent proteins that mediate vesicular-membrane fusion.
It was indeed shown that various types of voltage-gated
calcium channels were inhibited by volatile anesthetics such
as halothane and isoflurane and intravenous anesthetics
such as propofol (Asahina et al., 1998; Nikonorov et al., 1998;
Hirota et al., 1999; Kamatchi et al., 1999, 2001; Kameyama
et al., 1999; McDowell et al., 1999; Camara et al., 2001;
Hüneke et al., 2001; Yamakage and Namiki, 2002).
Aside from the presynaptic modulation of mEPSC and
mIPSC frequencies, halothane at 0.3, 0.6, and 1.2 mM in-
creased the duration and charge transfer of mIPSCs, pre-
sumably by a postsynaptic effect. This effect was also ob-
served with propofol at 1, 3, and 10 M. Neither agent,
however, affected the duration of the mEPSCs. This halo-
thane action on mIPSCs was observed at a concentration of
0.3 mM (1 MAC), suggesting that it may play a more
important role in the early induction of anesthesia than the
decreased mEPSC frequency seen at higher concentrations of
0.6 and 1.2 mM. It should be noted that halothane at 0.3 mM
significantly increased the charge transfer associated with
mIPSCs without effect on the frequency of mIPSCs. Thus,
the mIPSC charge transfer per unit time was also increased
by halothane at 0.3 mM. In a previously reported experiment
using human embryonic kidney cells transfected to express
the 122S GABA subunit combination, halothane was
found to increase the duration of GABA responses by reduc-
ing koff, the rate constant for agonist-receptor unbinding (Li
and Pearce, 2000). A similar effect may have occurred in the
present study in the cortical cell GABAA receptors in culture.
The effect of halothane and propofol in increasing net IPSC
Fig. 7. Effects of propofol on the amplitude, frequency, and decay time course of spontaneous IPSCs, non-EPSCs (NN-EPSCs), and NMDA EPSCs
(N-EPSCs). Data are normalized to control values and plotted against the anesthetic concentration. Propofol decreased the amplitude (A) and
frequency (B) of IPSCs, NN-EPSCs, and N-EPSCs only at high concentrations. Propofol increased in the decay time constant (C) and the total charge
transfer per IPSC (D) of spontaneous IPSCs. NN-EPSC and N-EPSC decay times were not affected. The numbers of experiments are indicated in
parentheses.
Halothane and Propofol on Synaptic Transmission 169
charge transfer occurred in both tonic spontaneous mIPSCs
(in the presence of TTX) and in action potential-driven phasic
IPSCs recorded in the absence of TTX. This implies that
halothane and propofol can enhance the tonic inhibitory neu-
ronal background activity, as well as the inhibition produced
by action potential-driven phasic GABA release. Note, how-
ever, that neither anesthetic increased the average peak
mIPSC amplitude. This suggests that in the cortical neuron
culture the release of even a single GABA-filled vesicle
nearly saturates the postsynaptic GABAA receptors because
the maximum GABA-induced current is not potentiated by
halothane or propofol.
It should be noted that unlike halothane, the only effect
observed with propofol is an increase in charge transfer as-
sociated with mIPSCs and IPSCs. This is in keeping with a
recent thiopental study that showed an enhancement of
GABergic transmission without effect on glutamatergic
transmission (Dickinson et al., 2002).
Higher concentrations of halothane (1.2 mM), however,
reduced the amplitude of spontaneous GABAergic mIPSCs.
This was also reported by Banks and Pearce (1999) for IPSCs
in hippocampal slices in the presence of the anesthetics en-
flurane and isoflurane. They concluded that anesthetic bind-
ing to a secondary, lower affinity site produced this inhibitory
effect distinct from the binding site that leads to IPSC pro-
longation. A similar two-site mode of action may also hold for
the duel effects of halothane observed in cultured cortical
neurons. A similar propofol-induced inhibition of the ampli-
tude was observed only on EPSCs in the TTX-free condition.
This propofol effect may stem from the anesthetic enhance-
ment of GABAergic transmission that, in turn, reduces the
spontaneous occurrence of action potential-driven EPSCs.
Overall, the present experiments indicate that the primary
effect of halothane is the increase in charge transfer during
both spontaneous mIPSCs and action potential-driven IP-
SCs. This action is observed at halothane concentrations
equivalent to 1 MAC, and seems to be responsible for causing
anesthesia. Propofol produces a similar effect. However, at
concentrations just over 2 MAC, halothane has the additional
effect of reducing the frequency of spontaneous mEPSCs and
mIPSCs. The former effect of halothane is expected to en-
hance the degree of anesthesia by reducing an endogenous
excitatory tone to the cells. The latter effect on IPSC fre-
quency could paradoxically oppose the augmentation of IPSC
charge transfer. Yet, it is clear that the prolongation and
increase in charge transfer of IPSCs caused by halothane at
1 MAC must prevail over any decrease in the spontaneous
mIPSC frequency observed at higher concentrations.
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